A Pilot Study to Characterise Saliva and Sputum FTIR Spectral Profiles in Patients with COPD During Exacerbations and When Stable
NCT04524819 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 27
Last updated 2024-11-08
Summary
This study will characterise saliva and sputum FTIR spectral profiles in patients with COPD, during exacerbations and stable disease.
Conditions
Sponsors & Collaborators
-
Portsmouth Hospitals NHS Trust
lead OTHER_GOV
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-18
- Primary Completion
- 2023-10-31
- Completion
- 2023-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Microbiological Diversity in Exhaled Air in COPD and Free of COPD
NCT05437198 ·Status: RECRUITING
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00159289 ·Status: WITHDRAWN ·Phase: NA
-
Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers
NCT02490358 ·Status: COMPLETED
-
Pulmonary and Extrapulmonary Impairments in Patients With Post COVID-19
NCT05381727 ·Status: COMPLETED
-
Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific
NCT03151395 ·Status: COMPLETED ·Phase: NA
-
Study to Identify the Reduction of Exacerbations Resulting in Hospital Admission in Patients With COPD.
NCT05440188 ·Status: COMPLETED
-
Impact of COVID-19 on Lung Function in COPD Patients.
NCT05770440 ·Status: RECRUITING
-
Impact of COVID19 on Asthma Patients in Spain
NCT05064501 ·Status: WITHDRAWN
-
Study to Explore the Relationship Between the Level of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device Against Existing Measures of Lung Disease
NCT04061291 ·Status: COMPLETED
-
Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
NCT00159302 ·Status: WITHDRAWN
-
Sputum and Plasma Levels of Nociceptin and Substance P in Patients With Asthma, COPD and Chronic Cough
NCT00173225 ·Status: UNKNOWN
-
Pulmonary Fibrosis During Severe COVID-19 Pneumonia
NCT04987528 ·Status: ACTIVE_NOT_RECRUITING
-
Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19
NCT04716023 ·Status: UNKNOWN
-
LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION
NCT04409275 ·Status: UNKNOWN
-
Clinical Features and Airways Inflammation in Never Smokers and Smokers With COPD
NCT03274791 ·Status: COMPLETED
-
Respiratory Pathogens of Patients With Asthma and COPD Exacerbations
NCT02866357 ·Status: COMPLETED
-
Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air
NCT00356629 ·Status: TERMINATED
-
Long Term Outcomes of Coronavirus Disease-19 (COVID-19)
NCT04715919 ·Status: COMPLETED
-
Collection of Lung Fluid and Tissue Samples for Research
NCT00471250 ·Status: RECRUITING
-
Markers for Chronic Obstructive Pulmonary Disease (COPD)
NCT00180622 ·Status: WITHDRAWN
-
Non-contact Proactive Remote Monitoring of COPD Exacerbations
NCT05598983 ·Status: RECRUITING
-
Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD
NCT01254032 ·Status: COMPLETED
-
Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases
NCT02807025 ·Status: UNKNOWN
-
A Cross Sectional, Diagnostic Accuracy Study to Validate the Use of a New Device(Inflammacheck™) in Diagnosing COPD
NCT04024657 ·Status: COMPLETED